News
California’s Proposition 209, passed in 1996, ended the consideration of students’ race as one factor in public higher education admissions, but did not apply to private colleges and universities. The Supreme Court’s recent landmark decision ended that distinction.
News
The impact of the AI transformation has understandably drawn calls for robust regulation of the use of AI, but to date there is little to no government oversight on the development and deployment of automated decision tools.
Podcast
CAPITOL WEEKLY PODCAST: Facing the first deficit in a decade, legislators finished hammering out a Budget deal with the governor this week. Our guest today is Chris Hoene, Executive Director of the California Budget & Policy Center. Hoene has been a Budget-watcher for decades, and helps us dig into the new Budget Deal.
Analysis
California’s Governor has three options when the Legislature sends the Governor a bill: Sign it; veto it; or, allow the bill to become law without the Governor’s signature.
News
After a years-long wait, young women have finally been granted equal access to a program that has proven to be a pipeline for state lawmakers.
News
Maya Polon stays focused on making sure the public realizes how the legislation she champions affects real people. “What I really love getting to do is finding someone with an inspiring story and connecting a reporter to them.”
Analysis
While mostly political, the feud between California Gov. Gavin Newsom and Florida Gov. Ron DeSantis occasionally veers into the personal.
Podcast
CAPITOL WEEKLY PODCAST: Susannah Delano, Executive Director at Close the Gap California, joined us to talk about the work of identifying and preparing women to run for elected office, and about the very real challenges women face when they choose to enter public life.
Analysis
Here are some practical tips that were shared with me for those working with the staff members of the Governor’s Legislative Unit.
News
Directors of the $12 billion California stem cell agency will face a fundamental question next week that could determine whether its efforts to produce revolutionary treatments for afflictions ranging from heart disease to cancer will live or die.